Annual Report  2013  Notes to Financial Statements Assumptions used in fair value calculations:  5. INVESTMENTS  Preferred LP Units:  The difference in the acquisition cost of Quetico and Agility at December 31, 2012 and December 31, 2013 is due to foreign currency  translation.  The Corporation estimated the fair value of the available for sale financial assets (Preferred LP and LLC Units) by evaluating a number  of different methods:  (a) A going concern value was calculated by calculating the discounted cash flow of the future expected distributions. Key  assumptions used include the discount rate used in the calculation. For each individual Partner, the Corporation considered a  number of different discount rate factors including what industry they operated in, the size of the company, the health of the  balance sheet and the ability of the historical earnings to cover the future distributions. This was supported by the historical yield  of the original investment, current investing yields, and the current yield of Alaris’ publicly traded shares and of other similar public  companies.  (b) A redemption or retraction value was calculated using the formula specified in each of the Partnership agreements alongside an  assessment of the likelihood of a redemption of the Preferred Units.  (c) A liquidation value was calculated using the formula specified in each of the Partnership agreements while considering an estimate  of the current value of the private company to determine if there would be sufficient value to cover the liquidation amount.  December 31, 2013  Acquisition Cost  Capitalized Cost  Net Cost  Fair Value  LifeMark Health  $  19,502,159  $  499,894  $  20,002,053  $  35,500,000  LMS  54,228,822  333,280  54,562,102  32,528,822  Solowave  32,500,000  511,253  33,011,253  32,600,000  KMH  54,800,000  559,192  55,359,192  55,431,198  Killick  41,250,000  257,544  41,507,544  44,800,000  Quetico  28,575,870  860,337  29,436,207  29,436,207  Labstat  41,200,000  518,944  41,718,944  39,718,944  Agility Health  21,352,230  712,284  22,064,514  22,064,514  SHS  15,000,000  512,014  15,512,014  -  SCR  40,000,000  486,389  40,486,389  40,486,389  Sequel  70,111,800  593,111  70,704,911  70,704,911  SMi  30,000,000  717,310  30,717,310  30,717,310  $  448,520,881  $  6,561,552  $  455,082,433  $  433,988,295  December 31, 2012  Acquisition Cost  Capitalized Cost  Net Cost  Fair Value  LifeMark Health  $  36,450,000  $  499,894  $  36,949,894  $  65,500,000  LMS  51,000,000  333,280  51,333,280  25,800,000  Solowave  32,500,000  511,253  33,011,253  31,500,000  KMH  54,800,000  504,513  55,304,513  55,376,519  Killick  36,250,000  257,544  36,507,544  37,600,000  Quetico  26,808,540  860,337  27,668,877  27,668,877  Labstat  41,200,000  518,944  41,718,944  41,718,944  Agility Health  12,457,500  604,562  13,062,062  13,062,062  $  291,466,040  $  4,090,327  $  295,556,367  $  298,226,402  54 